Song's team determined that serum CCL18 was obviously elevated in patients with breast carcinoma, and high CCL18 in the serum was linked with lymph node metastasis and worse histopathological typing, which was an independent influencing factor in the prognosis of patients with breast cancer 12. The gene discussed is CCL18; the disease is metastatic malignant neoplasm in the lymph nodes.